Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015). Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. The Journal of Biological Chemistry, 290(47), 28097–28106. https://doi.org/10.1074/jbc.M115.680090
Article CAS PubMed PubMed Central Google Scholar
Chen, B., Wen, X., Jiang, H., Wang, J., Song, N., & Xie, J. (2019). Interactions between iron and α-synuclein pathology in parkinson’s disease. Free Radical Biology & Medicine, 141, 253–260. https://doi.org/10.1016/j.freeradbiomed.2019.06.024
Czapski, G. A., Czubowicz, K., & Strosznajder, R. P. (2012). Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacological Reports, 64(5), 1179–1188. https://doi.org/10.1016/s1734-1140(12)70914-3
Article CAS PubMed Google Scholar
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., & Stockwell, B. R. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Article CAS PubMed PubMed Central Google Scholar
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., Prokisch, H., Trümbach, D., Mao, G., Qu, F., Bayir, H., Füllekrug, J., Scheel, C. H., Wurst, W., Schick, J. A., Kagan, V. E., Angeli, J. P., & Conrad, M. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13(1), 91–98. https://doi.org/10.1038/nchembio.2239
Article CAS PubMed Google Scholar
Fernández-Mendívil, C., Luengo, E., Trigo-Alonso, P., García-Magro, N., Negredo, P., & López, M. G. (2021). Protective role of microglial HO-1 Blockade in aging: Implication of iron metabolism. Redox Biology, 38, 101789. https://doi.org/10.1016/j.redox.2020.101789
Article CAS PubMed Google Scholar
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010). Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature, 468(7324), 696–700. https://doi.org/10.1038/nature09536
Article CAS PubMed PubMed Central Google Scholar
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013). Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biology, 1(1), 483–491. https://doi.org/10.1016/j.redox.2013.07.006
Article CAS PubMed PubMed Central Google Scholar
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003). Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathologica, 106(6), 518–526. https://doi.org/10.1007/s00401-003-0766-2
Article CAS PubMed Google Scholar
Jang, H., Kim, S., Lee, J. M., Oh, Y. S., Park, S. M., & Kim, S. R. (2017). Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of parkinson’s disease. Neuroreport, 28(5), 242–249. https://doi.org/10.1097/wnr.0000000000000740
Article CAS PubMed Google Scholar
Jankovic, J., & Tan, E. K. (2020). Parkinson’s disease: Etiopathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 91(8), 795–808. https://doi.org/10.1136/jnnp-2019-322338
Jian, X., Zhao, G., Chen, H., Wang, Y., Li, J., Xie, L., & Li, B. (2022). Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease. Computational and Structural Biotechnology Journal, 20, 5218–5225. https://doi.org/10.1016/j.csbj.2022.09.018
Article CAS PubMed PubMed Central Google Scholar
Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022). The role of Cystine/Glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer. Frontiers in Oncology, 12, Article 858462. https://doi.org/10.3389/fonc.2022.858462
Article CAS PubMed PubMed Central Google Scholar
Li, J., Cao, F., Yin, H. L., Huang, Z. J., Lin, Z. T., Mao, N., Sun, B., & Wang, G. (2020). Ferroptosis: Past, present and future. Cell Death & Disease, 11(2), Article 88. https://doi.org/10.1038/s41419-020-2298-2
Li, T., Liu, J., Huang, X., Xie, Y., Hu, Y., Xu, Q., Tang, B., Tan, J., & Guo, J. (2025). Deficiency of PLA2G6 induces ferroptosis in dopaminergic neurons and contributes to parkinson’s disease pathogenesis via disruption of PRDX6/FTH1/GPX4 axis. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05257-x
Article PubMed PubMed Central Google Scholar
Liu, Y., Wang, W., Li, Y., Xiao, Y., Cheng, J., & Jia, J. (2015). The 5-lipoxygenase inhibitor Zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis. Biological & Pharmaceutical Bulletin, 38(8), 1234–1239. https://doi.org/10.1248/bpb.b15-00048
Mansour, R. M., Ahmed, M. A. E., El-Sahar, A. E., & El Sayed, N. S. (2018). Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicology and Applied Pharmacology, 358, 76–85. https://doi.org/10.1016/j.taap.2018.09.012
Article CAS PubMed Google Scholar
Marques, C. F., Marques, M. M., & Justino, G. C. (2022). Leukotrienes vs. montelukast-Activity, metabolism, and toxicity hints for repurposing. Pharmaceuticals. https://doi.org/10.3390/ph15091039
Article PubMed PubMed Central Google Scholar
Marschallinger, J., Schäffner, I., Klein, B., Gelfert, R., Rivera, F. J., Illes, S., Grassner, L., Janssen, M., Rotheneichner, P., Schmuckermair, C., Coras, R., Boccazzi, M., Chishty, M., Lagler, F. B., Renic, M., Bauer, H.-C., Singewald, N., Blümcke, I., Bogdahn, U., … Aigner, L. (2015). Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nature Communications, 6(1), Article 8466. https://doi.org/10.1038/ncomms9466
Article CAS PubMed PubMed Central Google Scholar
Masaldan, S., Bush, A. I., Devos, D., Rolland, A. S., & Moreau, C. (2019). Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology & Medicine, 133, 221–233. https://doi.org/10.1016/j.freeradbiomed.2018.09.033
Michael, J., Marschallinger, J., & Aigner, L. (2019). The leukotriene signaling pathway: A druggable target in Alzheimer’s disease. Drug Discovery Today, 24(2), 505–516. https://doi.org/10.1016/j.drudis.2018.09.008
Article CAS PubMed Google Scholar
Michael, J., Unger, M. S., Poupardin, R., Schernthaner, P., Mrowetz, H., Attems, J., & Aigner, L. (2020). Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s disease mice. Acta Neuropathologica Communications, 8(1), Article 129. https://doi.org/10.1186/s40478-020-00989-4
Article CAS PubMed PubMed Central Google Scholar
Nagarajan, V. B., & Marathe, P. A. (2018). Effect of Montelukast in experimental model of Parkinson’s disease. Neuroscience Letters, 682, 100–105. https://doi.org/10.1016/j.neulet.2018.05.052
Article CAS PubMed Google Scholar
Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer’s disease and Parkinson’s disease. The New England Journal of Medicine, 348(14), 1356–1364. https://doi.org/10.1056/NEJM2003ra020003
Article CAS PubMed Google Scholar
Ramires, R., Caiaffa, M. F., Tursi, A., Haeggström, J. Z., & Macchia, L. (2004). Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug Montelukast. Biochemical and Biophysical Research Communications, 324(2), 815–821. https://doi.org/10.1016/j.bbrc.2004.09.125
Article CAS PubMed Google Scholar
Riederer, P., Monoranu, C., Strobel, S., Iordache, T., & Sian-Hülsmann, J. (2021). Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease. Journal Of Neural Transmission, 128(10), 1577–1598. https://doi.org/10.1007/s00702-021-02414-z
Comments (0)